ABO and FUT2 (secretor) genotyping of hemolyzing and nonhemolyzing patients
| Patient . | Age . | Sex . | Hemolysis (Y/N) . | Hemolysis grade . | Genotype FUT2 . | Secretor status . | Phenotype ABO, RhD . | Genotype ABO* . |
|---|---|---|---|---|---|---|---|---|
| 1 | 21 | M | Compensated† | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
| 2 | 54 | F | N | 385AA 428AA | NS | B pos | B.01/B.01 | |
| 3 | 51 | F | Y | 2 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
| 4 | 50 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
| 5 | 77 | F | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
| 6 | 73 | M | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.02 |
| 7 | 34 | F | N | 385AA 428AA | NS | A pos | A1.02 /O.01.02 | |
| 8 | 27 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
| 9 | 39 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
| 10 | 53 | F | N | 328AA 428GG | S | B pos | B.01/O.01.01 | |
| 11 | 74 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.02 | |
| 12 | 58 | F | Y | 1 | 328AA 428GG | S | AB pos | A1.01/B.01 |
| 13 | 64 | M | N | 328AA 428AG | S | A pos | A2.01/O.01.01 | |
| 14 | 70 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.02 | |
| 15 | 60 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
| 16 | 60 | M | Y | 3 | 385AA 428AA | NS | A pos | A1.01/O.01.01 |
| 17 | 76 | M | N | 385AA 428AG | S | A pos | A1.01/O.01.02 | |
| 18 | 48 | F | N | 385AA 428AG | S | A neg | A1.01/A2.01 | |
| 19 | 72 | F | Y | 2 | 385AA 428AG | S | AB pos | A1.01/B.01 |
| 20 | 46 | F | Y | 4 | 385AA 428GG | S | A pos | A1.01/O.01.01 |
| 21 | 54 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.01 | |
| 22 | 52 | F | N | 385AA 428AG | S | Apos | A1.01/O.01.01 | |
| 23 | 29 | F | Y | 1 | 385AT 428AG | NS‡ | B pos | B.01/O.01.01 |
| 24 | 60 | F | N | 385AA 428AG | S | A neg | A2.01/O.01.01 | |
| 25 | 43 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
| 26 | 62 | F | N | 385AA 428AG | S | B pos | B.01/O.01.01 | |
| 27 | 81 | M | Y | 4 | 385AA 428AG | S | AB pos | A1.01/B.01 |
| 28 | 63 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
| 29 | 53 | M | Y | 2 | 385AA 428AG | S | B pos | B.01/B.01 |
| 30 | 28 | F | Y | 1 | 385AA 428AG | S | B pos | B.01/B.01 |
| 31 | 26 | F | Y | 1 | 385AA 428AA | NS | B pos | B.01/O.01.02 |
| 32 | 63 | F | Y | 2 | 385AA 428AG | S | B pos | B.01/O.01.02 |
| 33 | 75 | F | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
| 34 | 56 | M | N | 385AA 428GG | S | B pos | B.01/O.01.02 | |
| 35 | 80 | F | Y | 2 | 385AA 428GG | S | A pos | A1.01/O.01.02 |
| 36 | 11 | M | N | 385AA 428AG | S | B pos | B.01/B.01 | |
| 37 | 63 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
| 38 | 19 | F | Y | 1 | 385AA 428AG | S | A1B pos | A1.01/B.01 |
| 39 | 59 | F | Y | 1 | 385AA 428GG | S | B pos | B.01/O.01.01 |
| 40 | 63 | M | Y | 4 | 385AA 428AA | NS | A1B pos | A1.01/B.01 |
| 41 | 82 | F | Y | 4 | 385AA 428AG | S | A1pos | A1.02/O.01.01 |
| 42 | 59 | F | Y | 4 | 385AA 428AG | S | A1Bpos | A1.01/B.01 |
| Patient . | Age . | Sex . | Hemolysis (Y/N) . | Hemolysis grade . | Genotype FUT2 . | Secretor status . | Phenotype ABO, RhD . | Genotype ABO* . |
|---|---|---|---|---|---|---|---|---|
| 1 | 21 | M | Compensated† | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
| 2 | 54 | F | N | 385AA 428AA | NS | B pos | B.01/B.01 | |
| 3 | 51 | F | Y | 2 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
| 4 | 50 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
| 5 | 77 | F | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
| 6 | 73 | M | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.02 |
| 7 | 34 | F | N | 385AA 428AA | NS | A pos | A1.02 /O.01.02 | |
| 8 | 27 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
| 9 | 39 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
| 10 | 53 | F | N | 328AA 428GG | S | B pos | B.01/O.01.01 | |
| 11 | 74 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.02 | |
| 12 | 58 | F | Y | 1 | 328AA 428GG | S | AB pos | A1.01/B.01 |
| 13 | 64 | M | N | 328AA 428AG | S | A pos | A2.01/O.01.01 | |
| 14 | 70 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.02 | |
| 15 | 60 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
| 16 | 60 | M | Y | 3 | 385AA 428AA | NS | A pos | A1.01/O.01.01 |
| 17 | 76 | M | N | 385AA 428AG | S | A pos | A1.01/O.01.02 | |
| 18 | 48 | F | N | 385AA 428AG | S | A neg | A1.01/A2.01 | |
| 19 | 72 | F | Y | 2 | 385AA 428AG | S | AB pos | A1.01/B.01 |
| 20 | 46 | F | Y | 4 | 385AA 428GG | S | A pos | A1.01/O.01.01 |
| 21 | 54 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.01 | |
| 22 | 52 | F | N | 385AA 428AG | S | Apos | A1.01/O.01.01 | |
| 23 | 29 | F | Y | 1 | 385AT 428AG | NS‡ | B pos | B.01/O.01.01 |
| 24 | 60 | F | N | 385AA 428AG | S | A neg | A2.01/O.01.01 | |
| 25 | 43 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
| 26 | 62 | F | N | 385AA 428AG | S | B pos | B.01/O.01.01 | |
| 27 | 81 | M | Y | 4 | 385AA 428AG | S | AB pos | A1.01/B.01 |
| 28 | 63 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
| 29 | 53 | M | Y | 2 | 385AA 428AG | S | B pos | B.01/B.01 |
| 30 | 28 | F | Y | 1 | 385AA 428AG | S | B pos | B.01/B.01 |
| 31 | 26 | F | Y | 1 | 385AA 428AA | NS | B pos | B.01/O.01.02 |
| 32 | 63 | F | Y | 2 | 385AA 428AG | S | B pos | B.01/O.01.02 |
| 33 | 75 | F | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
| 34 | 56 | M | N | 385AA 428GG | S | B pos | B.01/O.01.02 | |
| 35 | 80 | F | Y | 2 | 385AA 428GG | S | A pos | A1.01/O.01.02 |
| 36 | 11 | M | N | 385AA 428AG | S | B pos | B.01/B.01 | |
| 37 | 63 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
| 38 | 19 | F | Y | 1 | 385AA 428AG | S | A1B pos | A1.01/B.01 |
| 39 | 59 | F | Y | 1 | 385AA 428GG | S | B pos | B.01/O.01.01 |
| 40 | 63 | M | Y | 4 | 385AA 428AA | NS | A1B pos | A1.01/B.01 |
| 41 | 82 | F | Y | 4 | 385AA 428AG | S | A1pos | A1.02/O.01.01 |
| 42 | 59 | F | Y | 4 | 385AA 428AG | S | A1Bpos | A1.01/B.01 |
Only the last 4 patients were phenotyped for A1/A2.
F, female; M, male; N, no; neg, negative; NS = nonsecretor; pos, positive; RhD, rhesus factor; S = secretor; Y, yes. Bold indicates patients that hemolyzed.
ABO allele terminology here is according to the International Society of Blood Transfusion (www.isbt-web.org) and the Blood Group Antigen Facts Book.26
Compensated hemolysis is determined by positive direct antiglobulin test, Hgb drop < 10 g/L, and reticulocytosis.
Likely partial secretor (included in the nonsecretor group because very little ABO substance is expected in body fluids).